BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9375033)

  • 1. Decreased expression of bcl-2 (p26) in CD8(+) lymphocytes of patients with T-cell lymphoproliferative disorders of large granular lymphocytes.
    Lima M; Teixeira Mdos A; Dos Santos AH; Queirós ML; Justiça B
    Hematol Oncol; 1997 May; 15(2):81-91. PubMed ID: 9375033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of bcl-2 and susceptibility to programmed cell death in lymphocytes of HIV-1-infected individuals.
    Dobmeyer TS; Klein SA; Dobmeyer JM; Raffel B; Findhammer S; Hoelzer D; Helm EB; Rossol R; Kabelitz D
    Clin Immunol Immunopathol; 1998 Jun; 87(3):230-9. PubMed ID: 9646832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonally expanded CD3+, CD4-, CD8- cells bearing the alpha/beta or the gamma/delta T-cell receptor in patients with the lymphoproliferative disease of granular lymphocytes.
    Pandolfi F; Foa R; De Rossi G; Zambello R; Chisesi T; di Celle PF; Migone N; Casorati G; Scarselli E; Ensoli F
    Clin Immunol Immunopathol; 1991 Sep; 60(3):371-83. PubMed ID: 1830831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of FasR, Fas-L and Bcl-2 in CD4+ and CD8+ subpopulations of T lymphocytes in the cord blood of healthy full-term newborns, is gender of influence?
    Wasiluk A; Ratomski K; Wnuczko K; Zak J; Szczepański M; Wysocka J; Jasińska EA
    Adv Med Sci; 2009; 54(1):99-103. PubMed ID: 19482726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL-2 oncoprotein (p26) in splenic lymphoma with villous lymphocytes: a comparative study with other chronic B-cell disorders.
    Lima M; dos Anjos Teixeira M; Queirós ML; Ribeiro dos Santos AH; Justiça B
    Am J Hematol; 1997 Oct; 56(2):122-5. PubMed ID: 9326355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of Bcl-2, but not of Bax or Bcl-x, is associated with T lymphocyte apoptosis in HIV infection and restored by antiretroviral therapy or by interleukin 2.
    Regamey N; Harr T; Battegay M; Erb P
    AIDS Res Hum Retroviruses; 1999 Jun; 15(9):803-10. PubMed ID: 10381168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and flow cytometry characterization during the follow-up of three simultaneous lymphoproliferative disorders: hairy cell leukemia, monoclonal B-cell lymphocytosis, and CD4(++) /CD8(+/- dim) T-large granular lymphocytosis--a case report.
    Garrido P; Jiménez P; Sánchez C; Valero F; Balanzategui A; Almagro M; López P; de Pablos JM; Navarro P; Cabrera A; González M; Jurado M; Ruiz-Cabello F
    Cytometry B Clin Cytom; 2011 May; 80(3):195-200. PubMed ID: 21520406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCRalphabeta+/CD4+ large granular lymphocytosis: a new clonal T-cell lymphoproliferative disorder.
    Lima M; Almeida J; Dos Anjos Teixeira M; Alguero Md Mdel C; Santos AH; Balanzategui A; Queirós ML; Bárcena P; Izarra A; Fonseca S; Bueno C; Justiça B; Gonzalez M; San Miguel JF; Orfao A
    Am J Pathol; 2003 Aug; 163(2):763-71. PubMed ID: 12875995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naive CD4+ T lymphocytes express high levels of Bcl-2 after highly active antiretroviral therapy for HIV infection.
    Airò P; Torti C; Uccelli MC; Malacarne F; Palvarini L; Carosi G; Castelli F
    AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1805-7. PubMed ID: 11118066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of cyclosporine in up-regulation of Bcl-2 expression and maintenance of CD8 lymphocytosis in cytomegalovirus-infected allograft recipients.
    Labalette M; Queyrel V; Masy E; Noel C; Pruvot FR; Dessaint JP
    Transplantation; 1995 Jun; 59(12):1714-23. PubMed ID: 7541577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lymphocyte activation markers in patients with ovarian cancer].
    Nowicka A; Rogala E; Bednarek W; Barczyński B; Wertel I; Piekarczyk W; Kotarski J
    Ginekol Pol; 2012 Oct; 83(10):737-43. PubMed ID: 23383558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic regulation.
    Gratiot-Deans J; Ding L; Turka LA; Nuñez G
    J Immunol; 1993 Jul; 151(1):83-91. PubMed ID: 8326141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD3+ CD4+ and CD3+ CD8+ lymphocyte subgroups and their surface receptors NKG2D and NKG2A in patients with non-small cell lung cancer.
    Yu DP; Han Y; Zhao QY; Liu ZD
    Asian Pac J Cancer Prev; 2014; 15(6):2685-8. PubMed ID: 24761885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD3+, CD4-, CD8- large granular T-cell lymphoproliferative disorder.
    Sun T; Cohen NS; Marino J; Koduru P; Cuomo J; Henshall J
    Am J Hematol; 1991 Jul; 37(3):173-8. PubMed ID: 1650132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of pro- and antiapoptotic proteins in circulating CD8+ T cells of patients with squamous cell carcinoma of the head and neck.
    Kim JW; Tsukishiro T; Johnson JT; Whiteside TL
    Clin Cancer Res; 2004 Aug; 10(15):5101-10. PubMed ID: 15297413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression.
    Grossmann M; O'Reilly LA; Gugasyan R; Strasser A; Adams JM; Gerondakis S
    EMBO J; 2000 Dec; 19(23):6351-60. PubMed ID: 11101508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD8+ alpha beta+ T cells that lack surface CD5 antigen expression are a major lymphotactin (XCL1) source in peripheral blood lymphocytes.
    Stievano L; Tosello V; Marcato N; Rosato A; Sebelin A; Chieco-Bianchi L; Amadori A
    J Immunol; 2003 Nov; 171(9):4528-38. PubMed ID: 14568926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of bcl-2 protein in lymphocytes of patients with laryngeal carcinoma.
    Klatka J; Roliński J; Kupisz K; Klonowski S; Skomra D
    Eur Arch Otorhinolaryngol; 1999; 256(6):299-302. PubMed ID: 10456279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD5 costimulation up-regulates the signaling to extracellular signal-regulated kinase activation in CD4+CD8+ thymocytes and supports their differentiation to the CD4 lineage.
    Zhou XY; Yashiro-Ohtani Y; Toyo-Oka K; Park CS; Tai XG; Hamaoka T; Fujiwara H
    J Immunol; 2000 Feb; 164(3):1260-8. PubMed ID: 10640739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
    Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
    J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.